CClinicalTrials.gg
Status unknownNCT00292513Updated Feb 16, 2006

Clinical Trial Comparing Tissue Adhesive Vs. Absorbable Suture Vs. Non-Absorbable Suture

An interventional study of standard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut) in Cyst of Face, Neck or Shoulder and Pilomatrixoma of Face, Neck or Shoulder, sponsored by Rady Children's Hospital, San Diego. Status unknown at 1 site in United States. Open to participants aged 0 Years to 18 Years. Per ClinicalTrials.gov, last updated 2006-02-16.

Sponsored by Rady Children's Hospital, San Diego · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2005), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Allocation
Randomized
Ages
0 Years to 18 Years
Sex
All
01

Study summary

Standard suture is superior to both tissue adhesive (2-octyl cyanoacrylate) and absorbable sutures with respect to cosmetic outcome of, complication rate of and parental satisfaction with the closure of low tension facial, neck and shoulder, wounds in children and adolescents

02

Conditions studied

  • Cyst of Face, Neck or Shoulder
  • Pilomatrixoma of Face, Neck or Shoulder
03

In context

Lead sponsor

Rady Children's Hospital, San Diego is the lead sponsor of 11 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Years to 18 Years
Sexes eligible
All

Inclusion criteria

  • Age less than or equal to 18
  • Pre-operative diagnosis of cyst or pilomatrixoma of neck, face or shoulder
  • outpatient scheduled for outpatient or day surgery at Children's Hospital San Diego

Exclusion criteria

Exclusion Criteria:

  • known hypersensitivity to cyanoacrylate or formaldehyde
  • lesions with any evidence of active infection or gangrene
  • lesions on or across mucocutaneous surfaces
  • lesions in which skin may be regularly exposed to body fluids
  • lesions located in areas of dense natural hair (ie scalp)
  • patients with peripheral vascular disease, insulin dependent diabetes mellitis or blood clotting disorders
  • patients with known immunodeficiencies
  • inability to return for follow-up
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)

Interventions

  • Devicestandard suture (5-0 prolene), topical skin adhesive (dermabond), absorbable suture (5-0 Chromic gut)
06

Study locations

1 of 1 sites recruiting
  • Children's Hospital San Diego
    San Diego, California 92123, United States
    • Bari B Cunningham, MD · Principal investigator
    • Sheila F Friedlander, MD · Sub investigator
    • Lawrence F Eichenfield, MD · Sub investigator
    • Brandie Roberts, MD · Sub investigator
    • Magdalene Dohil, MD · Sub investigator
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 16, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00292513
Lead sponsor
Rady Children's Hospital, San Diego
First posted
Feb 16, 2006
Last update
Feb 16, 2006

Study contacts

Bari B Cunningham, MD
Contact
bcunningham@chsd.org
858-576-1700 ext. 4270
Bari B Cunningham, MD
principal investigator · Rady Children's Hospital, San Diego
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2005. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion